AU2013291941B2 - Method for increasing implantation success in assisted fertilization - Google Patents
Method for increasing implantation success in assisted fertilization Download PDFInfo
- Publication number
- AU2013291941B2 AU2013291941B2 AU2013291941A AU2013291941A AU2013291941B2 AU 2013291941 B2 AU2013291941 B2 AU 2013291941B2 AU 2013291941 A AU2013291941 A AU 2013291941A AU 2013291941 A AU2013291941 A AU 2013291941A AU 2013291941 B2 AU2013291941 B2 AU 2013291941B2
- Authority
- AU
- Australia
- Prior art keywords
- state
- endometrial
- uterine
- cells
- expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1089—Design, preparation, screening or analysis of libraries using computer algorithms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/367—Infertility, e.g. sperm disorder, ovulatory dysfunction
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Gynecology & Obstetrics (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Reproductive Health (AREA)
- Medicinal Chemistry (AREA)
- Pregnancy & Childbirth (AREA)
- Pathology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12177377.4A EP2687851A1 (en) | 2012-07-20 | 2012-07-20 | Method for increasing implantation success in assisted fertilization |
| EP12177377.4 | 2012-07-20 | ||
| PCT/EP2013/065355 WO2014013079A1 (en) | 2012-07-20 | 2013-07-19 | Method for increasing implantation success in assisted fertilization |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2013291941A1 AU2013291941A1 (en) | 2015-02-12 |
| AU2013291941B2 true AU2013291941B2 (en) | 2019-05-02 |
Family
ID=48874275
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2013291941A Active AU2013291941B2 (en) | 2012-07-20 | 2013-07-19 | Method for increasing implantation success in assisted fertilization |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US10450561B2 (https=) |
| EP (2) | EP2687851A1 (https=) |
| JP (1) | JP6411340B2 (https=) |
| CN (1) | CN104603622B (https=) |
| AU (1) | AU2013291941B2 (https=) |
| BR (1) | BR112015001157B1 (https=) |
| CA (1) | CA2879467C (https=) |
| DK (1) | DK2877856T3 (https=) |
| ES (1) | ES2740548T3 (https=) |
| HU (1) | HUE046835T2 (https=) |
| IL (1) | IL236824B (https=) |
| PL (1) | PL2877856T3 (https=) |
| PT (1) | PT2877856T (https=) |
| RU (1) | RU2730873C2 (https=) |
| SI (1) | SI2877856T1 (https=) |
| WO (1) | WO2014013079A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114927178A (zh) * | 2015-06-12 | 2022-08-19 | 格尼亚Ip控股私人有限公司 | 患者和生物样本识别和追踪的方法和系统 |
| WO2017054038A1 (en) | 2015-09-30 | 2017-04-06 | Prince Henry's Institute Of Medical Research Trading As The Hudson Institute Of Medical Research | A method of treatment and prognosis |
| CN105784983B (zh) * | 2016-01-13 | 2017-10-31 | 深圳中山生殖与遗传研究所 | 一种评估子宫内膜容受性的试剂盒及其使用方法 |
| CZ2017255A3 (cs) | 2017-05-04 | 2018-11-14 | Zentiva, K.S. | Filmem potažené tablety Deferasiroxu |
| EP3914915A1 (en) * | 2019-01-25 | 2021-12-01 | Fertility Lab Sciences, LLC | Uterine endometrial fluid for prediction of success in fertility treatment |
| CN110042156B (zh) | 2019-04-22 | 2021-12-28 | 苏州亿康医学检验有限公司 | 一种判断子宫内膜容受性的方法及其应用 |
| CN110148446B (zh) * | 2019-05-21 | 2023-06-16 | 重庆市柏玮熠科技有限公司 | Ivf样本核对系统 |
| CN114599798A (zh) * | 2019-06-25 | 2022-06-07 | 哈德逊医学研究所 | 预测子宫内膜容受性的方法 |
| GB201911947D0 (en) * | 2019-08-20 | 2019-10-02 | Univ Warwick | Miscarriage biomarkers |
| RU2732432C1 (ru) * | 2020-03-31 | 2020-09-16 | Федеральное государственное бюджетное учреждение "Уральский научно-исследовательский институт охраны материнства и младенчества" Министерства здравоохранения Российской Федерации (ФГБУ "НИИ ОММ" Минздрава России) | Способ оценки эндометриальной дисфункции у женщин с первичным эндометриоз-ассоциированным бесплодием |
| CN111624354A (zh) * | 2020-06-05 | 2020-09-04 | 佛山迪安医学检验实验室有限公司 | 一种诊断试剂盒及诊断方法 |
| CN111772682B (zh) * | 2020-07-10 | 2021-08-13 | 北京大学第三医院（北京大学第三临床医学院） | 预测受试者出现卵巢储备新变化年限的系统和方法 |
| CN111778326B (zh) * | 2020-07-14 | 2021-10-22 | 和卓生物科技（上海）有限公司 | 用于子宫内膜容受性评估的基因标志物组合及其应用 |
| RU2748191C1 (ru) * | 2021-01-21 | 2021-05-20 | Мекан Рахимбердыевич Оразов | Способ определения степени выраженности хронического эндометрита у женщин с маточным фактором бесплодия после неудачного экстракорпорального оплодотворения в анамнезе (варианты) |
| EP4407626A1 (fr) * | 2023-01-30 | 2024-07-31 | Sofia | Procédé de génération de recommandations diagnostiques et/ou thérapeutiques en fertilité |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR1004154B (el) * | 2001-05-21 | 2003-02-20 | Μεθοδος διερευνησης του ενδομητριου με εξετασεις που εφαρμοζονται επι του ιστου αποπεπτωκοτος ενδομητριου (ιστου περιοδου) | |
| US7175990B2 (en) | 2002-02-26 | 2007-02-13 | The Regents Of The University Of California | Method of determining endometrial receptivity |
| US20100150862A1 (en) * | 2006-12-07 | 2010-06-17 | Schering Corporation | Methods of modulating maternal-fetal tolerance |
| CN105224827B (zh) * | 2008-07-01 | 2019-12-24 | 小利兰·斯坦福大学托管委员会 | 用于发展ivf治疗协议的分析数据的计算机系统和存储介质 |
| WO2010010201A1 (es) | 2008-07-22 | 2010-01-28 | Equipo Ivi Investigacion Sl | Perfil de expresion genetica como marcador de la receptividad endometrial |
| WO2011000805A1 (en) * | 2009-06-29 | 2011-01-06 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Biomarkers of oocyte competency and method of use |
| EP2348318A1 (en) | 2010-01-21 | 2011-07-27 | Equipo Ivi Investigación, S.L. | Diagnostic method for endometrial receptivity |
| JP6219164B2 (ja) * | 2010-05-27 | 2017-10-25 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | 患者の子宮内膜の受容性を評価するための方法 |
| BR112013000879A2 (pt) * | 2010-07-13 | 2016-05-17 | Univfy Inc | método de avaliação do risco de nascimento múltiplos em travamentos para infertilidade |
| RU2444315C1 (ru) * | 2010-09-03 | 2012-03-10 | Михаил Григорьевич Шнейдерман | Способ повышения возможности удачной имплантации эмбриона к эндометрию полости матки |
-
2012
- 2012-07-20 EP EP12177377.4A patent/EP2687851A1/en not_active Withdrawn
-
2013
- 2013-07-19 CA CA2879467A patent/CA2879467C/en active Active
- 2013-07-19 BR BR112015001157-8A patent/BR112015001157B1/pt active IP Right Grant
- 2013-07-19 DK DK13740258.2T patent/DK2877856T3/da active
- 2013-07-19 EP EP13740258.2A patent/EP2877856B1/en active Active
- 2013-07-19 HU HUE13740258A patent/HUE046835T2/hu unknown
- 2013-07-19 CN CN201380046019.3A patent/CN104603622B/zh active Active
- 2013-07-19 WO PCT/EP2013/065355 patent/WO2014013079A1/en not_active Ceased
- 2013-07-19 PT PT13740258T patent/PT2877856T/pt unknown
- 2013-07-19 PL PL13740258T patent/PL2877856T3/pl unknown
- 2013-07-19 ES ES13740258T patent/ES2740548T3/es active Active
- 2013-07-19 JP JP2015522119A patent/JP6411340B2/ja active Active
- 2013-07-19 RU RU2016106004A patent/RU2730873C2/ru not_active Application Discontinuation
- 2013-07-19 US US14/415,987 patent/US10450561B2/en active Active
- 2013-07-19 AU AU2013291941A patent/AU2013291941B2/en active Active
- 2013-07-19 SI SI201331544T patent/SI2877856T1/sl unknown
-
2015
- 2015-01-20 IL IL236824A patent/IL236824B/en active IP Right Grant
Non-Patent Citations (3)
| Title |
|---|
| LÉDÉE N. ET AL., "New pre-conception immune biomarkers for clinical practice: interleukin-18, interleukin-15 and TWEAK on the endometrial side, G-CSF on the follicular side", J. REPROD. IMMUNOL., (2011-03), vol. 88, no. 2, pages 118 - 123 * |
| LÉDÉE-BATAILLE N. ET AL., FERTIL. STERIL., (2005-03), vol. 83, no. 3, pages 598 - 605 * |
| PETITBARAT M. ET AL., FERTIL. STERIL., (2010-08), vol. 94, no. 3, pages 1141 - 1143 * |
Also Published As
| Publication number | Publication date |
|---|---|
| PL2877856T3 (pl) | 2019-11-29 |
| BR112015001157B1 (pt) | 2022-03-29 |
| CA2879467C (en) | 2021-11-09 |
| EP2877856A1 (en) | 2015-06-03 |
| JP2015531057A (ja) | 2015-10-29 |
| ES2740548T3 (es) | 2020-02-05 |
| SI2877856T1 (sl) | 2019-11-29 |
| US10450561B2 (en) | 2019-10-22 |
| IL236824B (en) | 2018-06-28 |
| DK2877856T3 (da) | 2019-08-12 |
| WO2014013079A1 (en) | 2014-01-23 |
| EP2877856B1 (en) | 2019-07-10 |
| HK1210835A1 (en) | 2016-05-06 |
| AU2013291941A1 (en) | 2015-02-12 |
| RU2730873C2 (ru) | 2020-08-26 |
| RU2016106004A (ru) | 2017-12-08 |
| BR112015001157A2 (https=) | 2017-08-15 |
| CN104603622B (zh) | 2017-08-01 |
| US20150184152A1 (en) | 2015-07-02 |
| CA2879467A1 (en) | 2014-01-23 |
| HUE046835T2 (hu) | 2020-03-30 |
| PT2877856T (pt) | 2019-08-21 |
| EP2687851A1 (en) | 2014-01-22 |
| CN104603622A (zh) | 2015-05-06 |
| JP6411340B2 (ja) | 2018-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2013291941B2 (en) | Method for increasing implantation success in assisted fertilization | |
| Franasiak et al. | Vitamin D levels do not affect IVF outcomes following the transfer of euploid blastocysts | |
| Badawy et al. | Prediction and diagnosis of poor ovarian response: the dilemma | |
| Tola | The association between in vitro fertilization outcome and the inflammatory markers of complete blood count among nonobese unexplained infertile couples | |
| Lédée et al. | Levels of follicular G-CSF and interleukin-15 appear as noninvasive biomarkers of subsequent successful birth in modified natural in vitro fertilization/intracytoplasmic sperm injection cycles | |
| Papanikolaou et al. | Identification of the high-risk patient for ovarian hyperstimulation syndrome | |
| Liu et al. | Endometrial thickness as a predictor of ectopic pregnancy in 1125 in vitro fertilization-embryo transfer cycles: a matched case–control study | |
| Topkara Sucu et al. | New Immunological Indexes for the Effect of Systemic Inflammation on Oocyte and Embryo Development in Women With Unexplained Infertility: Systemic Immune Response Index and Pan‐Immune‐Inflammation Value | |
| Vijay et al. | Association between AMH levels and fertility/reproductive outcomes among women undergoing IVF: a retrospective study | |
| Huang et al. | Low basal serum testosterone level is detrimental to the embryo implantation in the patients with severe endometriosis | |
| Chen et al. | Measurement of four novel endometrial NK cell subsets by multiplex staining in women with reproductive failure: A comparison with fertile controls | |
| Dumancic et al. | Histopathologic characteristics of term placentas in singleton pregnancies in women with endometriosis-related infertility after ART treatment: case-control study | |
| Wu et al. | Development of a machine learning–based prediction model for clinical pregnancy of intrauterine insemination in a large Chinese population | |
| El-Halawaty et al. | Assessment of male serum anti-Mullerian hormone as a marker of spermatogenesis and ICSI outcome | |
| Wyroba et al. | Anti-Müllerian hormone concentrations in women of different reproductive age and the chances of IVF outcome: A paradigm shift is needed | |
| Ibis et al. | Testicular sperm retrieval for intracytoplasmic sperm injection: when to consider it after unsuccessful intracytoplasmic sperm injection with ejaculated sperm? | |
| Wong et al. | Do uterine natural killer cell numbers in peri-implantation endometrium predict hypertensive disorder in pregnancy in women with a history of reproductive failure? | |
| Løssl et al. | Predictive value of plasma human chorionic gonadotropin measured 14 days after Day‐2 single embryo transfer | |
| Zhao et al. | The serum oestradiol/progesterone ratio on the day of OPU+ 7, but not the day of OPU+ 5, affects the rates of live birth in fresh blastocyst embryo transfer cycles | |
| HK1210835B (en) | Method for increasing implantation success in assisted fertilization | |
| George et al. | The role of reproductive immunology in recurrent pregnancy loss and repeated implantation failure | |
| Malcom et al. | Ongoing pregnancy rate is associated with trigger-day progesterone level in letrozole/clomiphene intrauterine insemination cycles | |
| Campitiello et al. | Endometrial LGR7 expression and implantation failure | |
| Ledee et al. | Using endometrial immune profiling in young IVF patients: implantation rates improved for morphologically sub-optimal embryos | |
| Kaser et al. | When is treatment with clomiphene or gonadotropin IUI futile? Results of FASTT and FORT-T, two prospective randomized controlled trials |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) |